“Translating Discovery to Cure” was the theme of the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO), which was held October 21-24, 2018, in San Antonio, Texas. Two posters included focused ultrasound research. The Columbia group presented data from their preclinical study using focused ultrasound to open the blood-brain barrier for drug delivery after stereotactic radiosurgery. A collaborative Canadian group presented interim results from a large clinical trial of recurrent cancer after radiation therapy. Focused ultrasound is one of the salvage treatments used after biochemical failure of prostate cancer treatment.
Focused Ultrasound Abstracts
SU44-2439: Focused Ultrasound Induced-Blood-Brain Barrier Opening in Post-Radiosurgery Mouse Brain for Locally-Enhanced Systemic Therapy by S. Wang, C.C. Wu, H. Zhang, M.E. Karakatsani, Y. Han, K.R. Chaudhary, E.E. Konofagou, S.K. Cheng
SU29-2294: Advanced Prostate Imaging of Recurrent Cancer after Radiation Therapy (PICs): Interim Results of a Prospective, Multi-Center Trial by W. Liu, H.T. Chung, P. Chung, K. Zukotynski, U. Metser, I. Rachinsky, R. Wolfson, S. Archer, L. Emmett, G.S. Baumank (Poster).
The abstracts have been published in the November 2018, issue of the Red Journal (the International Journal of Radiation Oncology Biology Physics).